These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22981350)

  • 21. Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival.
    Dai J; Jin G; Dong J; Chen Y; Xu L; Hu Z; Shen H
    J Thorac Oncol; 2010 Nov; 5(11):1748-54. PubMed ID: 20881643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of cyclin D1 expression and patient's survival in non-small-cell lung cancer: a systematic review with meta-analysis.
    Zhang LQ; Jiang F; Xu L; Wang J; Bai JL; Yin R; Wu YQ; Meng LJ
    Clin Lung Cancer; 2012 May; 13(3):188-95. PubMed ID: 22133292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients.
    Chen P; Li J; Ge LP; Dai CH; Li XQ
    Respirology; 2010 Apr; 15(3):501-9. PubMed ID: 20210890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between survivin expression and prognosis in non-small cell lung cancer.
    Atikcan S; Unsal E; Demirag F; Köksal D; Yilmaz A
    Respir Med; 2006 Dec; 100(12):2220-6. PubMed ID: 16650973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A candidate single nucleotide polymorphism in the 3' untranslated region (rs17878624) of survivin gene for NSCLC.
    Aynaci E; Coskunpinar E; Yildiz P
    Cell Mol Biol (Noisy-le-grand); 2018 Mar; 64(4):119-122. PubMed ID: 29631694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of survivin and Bcl-2 expression on the biological behavior of non-small cell lung cancer.
    Gao Q; Yang S; Kang MQ
    Mol Med Rep; 2012 Jun; 5(6):1409-14. PubMed ID: 22446832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of matrix metalloproteinase 9 expression in patients with non-small cell lung cancer.
    Peng WJ; Zhang JQ; Wang BX; Pan HF; Lu MM; Wang J
    Clin Chim Acta; 2012 Jul; 413(13-14):1121-6. PubMed ID: 22465234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of TTF-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Qian HH; Xu TS; Cai XQ; Ji TL; Guo HX
    Clin Chim Acta; 2015 Dec; 451(Pt B):208-14. PubMed ID: 25661085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis.
    Hu M; Hu Y; He J; Li B
    PLoS One; 2016; 11(1):e0147374. PubMed ID: 26824699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical significance and diagnostic value of Survivin autoantibody in non-small cell lung cancer patients].
    Ma L; Yue W; Zhang L; Wang Y; Zhang C; Yang X
    Zhongguo Fei Ai Za Zhi; 2010 Jul; 13(7):706-12. PubMed ID: 20673487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mechanism of radiosensitization by YM155, a novel small molecule inhibitor of survivin expression, is associated with DNA damage repair.
    Hu S; Fu S; Xu X; Chen L; Xu J; Li B; Qu Y; Yu H; Lu S; Li W
    Cell Physiol Biochem; 2015; 37(3):1219-30. PubMed ID: 26418254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of survivin and proliferating cell nuclear antigen in human non-small cell lung cancer].
    Zhou JM; Zhou JH; Deng ZH; Zheng H; Jiang HY; Cao HQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):544-8. PubMed ID: 16320585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic and clinicopathological significance of survivin expression in bladder cancer patients: a meta-analysis.
    Lv S; Turlova E; Zhao S; Kang H; Han M; Sun HS
    Tumour Biol; 2014 Feb; 35(2):1565-74. PubMed ID: 24101190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survivin over-expression is correlated with a poor prognosis in esophageal cancer patients.
    Xia H; Chen S; Huang H; Ma H
    Clin Chim Acta; 2015 Jun; 446():82-5. PubMed ID: 25896962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survivin expression in non-small-cell lung carcinomas: correlation with apoptosis and other apoptosis-related proteins, clinicopathologic prognostic factors and prognosis.
    Ulukus EC; Kargi HA; Sis B; Lebe B; Oztop I; Akkoclu A; Onen A; Sanli A
    Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):31-7. PubMed ID: 17536304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between survivin genetic polymorphisms and epidermal growth factor receptor mutation in non-small-cell lung cancer.
    Liu TC; Hsieh MJ; Wu WJ; Chou YE; Chiang WL; Yang SF; Su SC; Tsao TC
    Int J Med Sci; 2016; 13(12):929-935. PubMed ID: 27994498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear survivin expression: a prognostic factor for the response to taxane-platinum chemotherapy in patients with advanced non-small cell lung cancer.
    Wu YK; Huang CY; Yang MC; Lan CC; Lee CH; Chan EC; Chen KT
    Med Oncol; 2014 Aug; 31(8):79. PubMed ID: 24961465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VEGF-C in non-small cell lung cancer: meta-analysis.
    Jiang H; Shao W; Zhao W
    Clin Chim Acta; 2014 Jan; 427():94-9. PubMed ID: 24144865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear survivin as a biomarker for non-small-cell lung cancer.
    Lu B; Gonzalez A; Massion PP; Shyr Y; Shaktour B; Carbone DP; Hallahan DE
    Br J Cancer; 2004 Aug; 91(3):537-40. PubMed ID: 15266313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of serum levels of angiopoietin-2 and survivin biomarkers in non-small cell lung cancer.
    Fawzy A; Gaafar R; Kasem F; Ali SS; Elshafei M; Eldeib M
    J Egypt Natl Canc Inst; 2012 Mar; 24(1):41-5. PubMed ID: 23587231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.